Other examples include reduced methylation of the peroxisome proliferator-activated receptor alpha (PPARα) and glucocorticoid receptor (GR) genes; increased expression of these genes is associated with an increased risk of metabolic syndrome and cardiovascular disease [65]. This evidence concerns the gene PPARA and cardiovascular disorder.